$GWPC Latest Release WholeHEALTH Products Inc.
Post# of 8672
Posted On: 11/04/2014 9:30:14 AM
$GWPC Latest Release
WholeHEALTH Products Inc. is extremely pleased to announce completion of its Global Distribution Rights for the Real Time PCR Rapid Ebola Test
PR Newswire
WholeHEALTH Products Inc. 14 hours ago
ANAHEIM, Calif., Nov. 3, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHEALTH Products Inc. (GWPC) is a diversified company. WholeHEALTH Products Inc. is focused on leveraging the power and convenience of advanced technology and proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHEALTH Products' comprehensive line of 18 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and 8 retail consumer tests is your partner in the business of science.
View photo
.
Do It For The Ones You Love
WholeHEALTH Products will market its PCR Rapid Ebola Test directly to Africa and South American countries, while WholeHEALTH applies for FDA Emergency Use Approval (EUA) for the US market shortly.
The WholeHEALTH Products PCR Rapid Diagnostic Ebola Whole Blood Test can be done in 3 hours—a vast improvement over waiting days with the present testing.
WholeHEALTH Products' experienced CSO worked with China on the SARS virus, developed a Rapid Diagnostic Test for the H1N1 (Bird Flu), and is heading up the completion of the Rapid Real Time PCR Diagnostic Test for Ebola.
Some fever screening will begin, but the need for a rapid diagnostic test is paramount for airports, once a person has been detected to have a fever. The fever is not the issue; the airports need to find out right away if this person has Ebola so further testing, quarantine and emergency care issues can be addressed.
WholeHEALTH Products' soon-to-be announced Rapid 15 Minute Lateral Flow Ebola Diagnostic Test will do just that; it will determine with 99% accuracy if the person has Ebola. Once WholeHEALTH Products completes its Phase 3 in-house study, it will file for the EUA (Emergency Use Approval) for this test as well.
As of 10 October 2014, Africa has reported 8,376 suspected cases resulting in the deaths of 4,024. Although the Ebola death rate is alarming, the possibility of the virus spreading is ultra critical. There are several other viruses that kill hundreds of thousands or millions of people throughout the world, such as Dengue Fever, Malaria, HIV, and TB, but the spread of these diseases is not as easy as the spread of the Ebola virus.
The need to stop the spread of Ebola is imperative due to the easy transmission of the virus, and the death rate of the victims. Human-to-human transmission occurs only via direct contact with blood or body fluid from an infected person (including embalming of an infected dead body), or by contact with objects contaminated by the virus. Other body fluids that may transmit Ebola viruses include saliva, mucus, vomit, feces, sweat, tears, breast milk, urine, and semen. Entry points include the nose, mouth, eyes, or open wounds, cuts and abrasions.
The sooner the disease is diagnosed, the sooner treatment can begin, and the better the chances of survival. WholeHEALTH Products' PCR Real Time Ebola Rapid Diagnostic Test will take only 3 hours. Their Rapid 15 Minute Lateral Flow Ebola Diagnostic Test is currently in Phase 3 and WholeHEALTH Product anticipates that to be completed by the end of November.
Inspired by its slogan, "Love Life Live Long," WholeHealth is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives.
www.wholehealth-products.com
WholeHealth Products is your partner in the "Business of Science".
Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be
Photo - http://photos.prnewswire.com/prnh/20141103/156360
WholeHEALTH Products Inc. is extremely pleased to announce completion of its Global Distribution Rights for the Real Time PCR Rapid Ebola Test
PR Newswire
WholeHEALTH Products Inc. 14 hours ago
ANAHEIM, Calif., Nov. 3, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHEALTH Products Inc. (GWPC) is a diversified company. WholeHEALTH Products Inc. is focused on leveraging the power and convenience of advanced technology and proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHEALTH Products' comprehensive line of 18 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and 8 retail consumer tests is your partner in the business of science.
View photo
.
Do It For The Ones You Love
WholeHEALTH Products will market its PCR Rapid Ebola Test directly to Africa and South American countries, while WholeHEALTH applies for FDA Emergency Use Approval (EUA) for the US market shortly.
The WholeHEALTH Products PCR Rapid Diagnostic Ebola Whole Blood Test can be done in 3 hours—a vast improvement over waiting days with the present testing.
WholeHEALTH Products' experienced CSO worked with China on the SARS virus, developed a Rapid Diagnostic Test for the H1N1 (Bird Flu), and is heading up the completion of the Rapid Real Time PCR Diagnostic Test for Ebola.
Some fever screening will begin, but the need for a rapid diagnostic test is paramount for airports, once a person has been detected to have a fever. The fever is not the issue; the airports need to find out right away if this person has Ebola so further testing, quarantine and emergency care issues can be addressed.
WholeHEALTH Products' soon-to-be announced Rapid 15 Minute Lateral Flow Ebola Diagnostic Test will do just that; it will determine with 99% accuracy if the person has Ebola. Once WholeHEALTH Products completes its Phase 3 in-house study, it will file for the EUA (Emergency Use Approval) for this test as well.
As of 10 October 2014, Africa has reported 8,376 suspected cases resulting in the deaths of 4,024. Although the Ebola death rate is alarming, the possibility of the virus spreading is ultra critical. There are several other viruses that kill hundreds of thousands or millions of people throughout the world, such as Dengue Fever, Malaria, HIV, and TB, but the spread of these diseases is not as easy as the spread of the Ebola virus.
The need to stop the spread of Ebola is imperative due to the easy transmission of the virus, and the death rate of the victims. Human-to-human transmission occurs only via direct contact with blood or body fluid from an infected person (including embalming of an infected dead body), or by contact with objects contaminated by the virus. Other body fluids that may transmit Ebola viruses include saliva, mucus, vomit, feces, sweat, tears, breast milk, urine, and semen. Entry points include the nose, mouth, eyes, or open wounds, cuts and abrasions.
The sooner the disease is diagnosed, the sooner treatment can begin, and the better the chances of survival. WholeHEALTH Products' PCR Real Time Ebola Rapid Diagnostic Test will take only 3 hours. Their Rapid 15 Minute Lateral Flow Ebola Diagnostic Test is currently in Phase 3 and WholeHEALTH Product anticipates that to be completed by the end of November.
Inspired by its slogan, "Love Life Live Long," WholeHealth is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives.
www.wholehealth-products.com
WholeHealth Products is your partner in the "Business of Science".
Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be
Photo - http://photos.prnewswire.com/prnh/20141103/156360
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼